Compare Kaltura Inc (KLTR) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kaltura Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Kaltura Inc trades at $1.63 (market cap $249.42M), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 329× Kaltura Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Kaltura Inc pays none. Which is the better fit depends on your goals.
| KLTR | REGN | |
|---|---|---|
Market Cap | $249.42M | $82.06B |
Sector | Technology | Health |
52-Week High | $1.89 | $812.27 |
52-Week Low | $1.08 | $555.51 |
Enterprise Value | $261.64M | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Kaltura Inc
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)
Read more on KLTR →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
